Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Hybrid Effectiveness-implementation Study to Assess the Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Five Districts in Karamoja Region, Uganda

NCT05323721 is registered in ClinicalTrials.gov with Malaria Consortium as lead sponsor.

NCT NCT05323721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05323721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Hybrid Effectiveness-implementation Study to Assess the Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Five Districts in Karamoja Region, Uganda
Lead sponsor
Malaria Consortium
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2022
Completion date
December 1, 2023
Enrollment
6,805 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria